These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38129722)

  • 1. Cardiac disease in Cushing's syndrome. Emphasis on the role of cardiovascular magnetic resonance imaging.
    Moustaki M; Markousis-Mavrogenis G; Vryonidou A; Paschou SA; Mavrogeni S
    Endocrine; 2024 Mar; 83(3):548-558. PubMed ID: 38129722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac structure and function in Cushing's syndrome: a cardiac magnetic resonance imaging study.
    Kamenický P; Redheuil A; Roux C; Salenave S; Kachenoura N; Raissouni Z; Macron L; Guignat L; Jublanc C; Azarine A; Brailly S; Young J; Mousseaux E; Chanson P
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2144-53. PubMed ID: 25093618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of cardiac structure and function abnormalities in patients with Cushing's syndrome before and after cure.
    Toja PM; Branzi G; Ciambellotti F; Radaelli P; De Martin M; Lonati LM; Scacchi M; Parati G; Cavagnini F; Pecori Giraldi F
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):332-8. PubMed ID: 21854405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study.
    Ehrlich K; Morbach C; Reiter T; Heuschmann PU; Hannemann A; Fassnacht M; Störk S; Hahner S; Deutschbein T
    BMC Endocr Disord; 2021 Jan; 21(1):11. PubMed ID: 33419423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac magnetic resonance reveals biventricular impairment in Cushing's syndrome: a multicentre case-control study.
    Feola T; Cozzolino A; De Alcubierre D; Pofi R; Galea N; Catalano C; Simeoli C; Di Paola N; Campolo F; Pivonello R; Isidori AM; Giannetta E
    Endocrine; 2024 May; ():. PubMed ID: 38775914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography.
    Neary NM; Booker OJ; Abel BS; Matta JR; Muldoon N; Sinaii N; Pettigrew RI; Nieman LK; Gharib AM
    J Clin Endocrinol Metab; 2013 May; 98(5):2045-52. PubMed ID: 23559084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease in Cushing's syndrome: heart versus vasculature.
    De Leo M; Pivonello R; Auriemma RS; Cozzolino A; Vitale P; Simeoli C; De Martino MC; Lombardi G; Colao A
    Neuroendocrinology; 2010; 92 Suppl 1():50-4. PubMed ID: 20829618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.
    Schernthaner-Reiter MH; Siess C; Gessl A; Scheuba C; Wolfsberger S; Riss P; Knosp E; Luger A; Vila G
    Endocrine; 2019 Apr; 64(1):157-168. PubMed ID: 30467627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics for the Improvement of Cushing's Syndrome Complicated With Cardiomyopathy After Treatment With a Literature Review.
    Miao S; Lu L; Li L; Wang Y; Lu Z; Zhu H; Wang L; Duan L; Xing X; Yao Y; Feng M; Wang R
    Front Cardiovasc Med; 2021; 8():777964. PubMed ID: 34926625
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased myocardial fibrosis and left ventricular dysfunction in Cushing's syndrome.
    Yiu KH; Marsan NA; Delgado V; Biermasz NR; Holman ER; Smit JW; Feelders RA; Bax JJ; Pereira AM
    Eur J Endocrinol; 2012 Jan; 166(1):27-34. PubMed ID: 22004909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess.
    Pivonello R; De Martino MC; Iacuaniello D; Simeoli C; Muscogiuri G; Carlomagno F; De Leo M; Cozzolino A; Colao A
    Front Horm Res; 2016; 46():54-65. PubMed ID: 27212264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease.
    Mavrogeni S; Katsi V; Vartela V; Noutsias M; Markousis-Mavrogenis G; Kolovou G; Manolis A
    BMC Cardiovasc Disord; 2017 May; 17(1):132. PubMed ID: 28535761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging diagnostic methods and imaging modalities in cushing's syndrome.
    Wright K; van Rossum EFC; Zan E; Werner N; Harris A; Feelders RA; Agrawal N
    Front Endocrinol (Lausanne); 2023; 14():1230447. PubMed ID: 37560300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbed bone marrow adiposity in patients with Cushing's syndrome and glucocorticoid- and postmenopausal- induced osteoporosis.
    Sørensen NN; Andreasen CM; Jensen PR; Hauge EM; Bollerslev J; Delaissé JM; Kassem M; Jafari A; Diaz-delCastillo M; Andersen TL
    Front Endocrinol (Lausanne); 2023; 14():1232574. PubMed ID: 37881495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies.
    Andela CD; van Haalen FM; Ragnarsson O; Papakokkinou E; Johannsson G; Santos A; Webb SM; Biermasz NR; van der Wee NJ; Pereira AM
    Eur J Endocrinol; 2015 Jul; 173(1):R1-14. PubMed ID: 25650405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypokalemia, diabetes mellitus, and hypercortisolemia are the major contributing factors to cardiac dysfunction in adrenal Cushing's syndrome.
    Takagi S; Tanabe A; Tsuiki M; Naruse M; Takano K
    Endocr J; 2009; 56(8):1009-18. PubMed ID: 19789419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing's syndrome: A pilot noninvasive study by transthoracic Doppler echocardiography.
    Tona F; Boscaro M; Barbot M; Maritan L; Famoso G; Dal Lin C; Montisci R; Fallo F; Iliceto S; Scaroni C
    Microvasc Res; 2020 Mar; 128():103940. PubMed ID: 31678361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.